sale newly issued securities in the category of of debt securities to high-net-worth investors on a program basis without providing its securities for credit rating prior to the offer for sale of the

for sale newly issued securities shares for a private placement without obtaining a prior approval from the SEC on 11 October, 2017. SEC Act S.300 in conjunction with 33 Settlement Committee Meeting

for a private placement without obtaining a prior approval from the SEC on 7 March, 2018. SEC Act S.300 in conjunction with 33 Settlement Committee Meeting No. 4/2019 Settlement Committee Order No

PTG’s Q3/2018 performance which would significantly worsen through her securities trading accounts during 4 – 5 October 2018 prior to the disclosure of such inside information to the public on 8

PTG’s Q3/2018 performance which would significantly worsen through his securities trading accounts on 4 October 2018 prior to the disclosure of such inside information to the public on 8 November 2018

PTG’s Q3/2018 performance which would significantly worsen through his securities trading accounts during 3 September 2018 to 2 November 2018 prior to the disclosure of such inside information to the

significantly worsen. Subsequently, during 3 September 2018 to 5 November 2018 prior to PTG’s disclosure of such inside information to the public on 8 November 2018, Mr. Tharathon sold PTG stocks by using such

2018 compared to the prior year was increasing in net profit amounting to Baht 30.48 million or 208.01% because of the following main reasons. 1. Revenue from hospital operations increased by Bath 45.32

million, we wish to clarify the changes in our operating results as follows: ‐ Sales Revenue was increased by Baht 18.30 million or 8.71% compared the same period of prior year. Export Sales Revenue was

Public Company Limited ( “ the Company”) compared with the same quarter of the prior period are as follows: (Unit: Million Baht) Quarter 1 2021 2020 QoQ (%) Total Revenues 1,387.65 745.78 86.07% Gross